Category Archives: marrow-infiltrating lymphocyte

Researchers safely use immune cells to treat multiple myeloma in human trials.


In a report on what is believed to be the first small clinical trial of its kind, researchers at the Johns Hopkins Kimmel Cancer Center say they have safely used immune cells grown from patients’ own bone marrow to treat multiple myeloma, a cancer of white blood cells. Experts report there are more than 20,000 new cases of multiple myeloma

Read more